The company's board voted unanimously to name Bokhari permanent CEO
Inc (HUGE:CSE) (OTCMKTS:FSDDF) has decided to keep interim CEO Raza Bokhari around a lot longer.
The pharmaceutical-grade cannabis company’s board voted unanimously to appoint Bokhari as its CEO, a position he has held on an interim basis since February.
He also serves as FSD’s executive co-chairman, as well as chairman of Parkway Clinical Laboratories, a diagnostic testing provider. In addition, Bokhari is a managing partner at the private equity fund RBxCapital.
READ: FSD Pharma taps longtime pharma exec to head its biosciences division
In 2005, he was awarded the 40 Under 40 Award by the Philadelphia Business Journal.
"As interim CEO, Dr. Bokhari has already navigated the company through some tough decisions, and he is rapidly advancing our strategic vision and mission to become a market leader in medicinal cannabis and cannabinoid pharmaceutical applications,” founder and executive co-chairman Anthony Durkacz said. “It was a logical and easy decision for the board to unanimously appoint Dr. Bokhari permanent CEO in addition to his role as the executive co-chairman."
FSD is focused on the research and development of cannabinoid-based treatments for central nervous system disorders such as fibromyalgia and irritable bowel syndrome.
Its shares slipped 10% to C$0.18 in Toronto and 11% to US$0.14 on OTC markets.
Contact Andrew Kessel at [email protected]
Follow him on @andrew_kessel
CSE:HUGE
Market: CSE
Market Cap: $63.39 m
Follow
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of FSD Pharma named herein, including the promotion by the Company of FSD Pharma in any Content on the Site, the Company receives from said issuer...
FOR OUR FULL DISCLAIMER CLICK HEREMost read
FSD Pharma rings the Nasdaq opening bell in 'exciting and momentous moment'
FSD Pharma Inc (NASDAQ:HUGE) (CSE:HUGE) CEO Raza Bokhari, who runs the pharmaceutical cannabis research company, rang the Nasdaq opening bell together with with members of the board, leadership team, early investors, and others. Bokhari says it was an 'exciting and momentous moment' for the...
1 week, 2 days ago
2 min read
Prev article
2 min read